Recent research from the American Action Forum detailed the cost
of insulin from the 1990s through 2020, based on data from the Centers for
Medicare and Medicaid Services. Growth in insulin prices has been accelerating
since 1991, with a reprieve only in recent years. The list price of insulin per
milliliter in the United States increased, on average, 2.9 percentannually
from 1991-2001, 9.5 percent annually from 2002-2012, 20.7 percent annually from 2012-2016, and 1.5 percentannually from 2016-2018. New data show that this
slower growth turned into broad price reductions for the first time in 2020 for
all insulin types except newer ultra-long-acting insulins, as shown in the
chart below. The average price across all insulin products fell 6.2 percent
from 2018-2020; however, average prices per unit are still double what they
were in 2012. Of note, the data are for list prices and do not account for
rebates, which are generally known to be quite large in the insulin market.
Note: The U.S. population is 332,615,808.
https://www.americanactionforum.org/weekly-checkup/actual-action-on-health-related-policy/#ixzz7Qy5J2w00
Follow@AAF on Twitter
No comments:
Post a Comment